Dr Reddy's Laboratories Ltd RDY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:47 AM EDT
73.65quote price arrow up+1.34 (+1.85%)
Volume
38,437
52 week range
53.12 - 77.72
Loading...
  • Open73.15
  • Day High73.68
  • Day Low73.04
  • Prev Close72.31
  • 52 Week High77.72
  • 52 Week High Date02/23/24
  • 52 Week Low53.12
  • 52 Week Low Date05/18/23

Key Stats

  • Market Cap12.264B
  • Shares Out166.52M
  • 10 Day Average Volume0.20M
  • Dividend0.48
  • Dividend Yield0.66%
  • Beta0.58
  • YTD % Change5.75

KEY STATS

  • Open73.15
  • Day High73.68
  • Day Low73.04
  • Prev Close72.31
  • 52 Week High77.72
  • 52 Week High Date02/23/24
  • 52 Week Low53.12
  • 52 Week Low Date05/18/23
  • Market Cap12.264B
  • Shares Out166.52M
  • 10 Day Average Volume0.20M
  • Dividend0.48
  • Dividend Yield0.66%
  • Beta0.58
  • YTD % Change5.75

RATIOS/PROFITABILITY

  • EPS (TTM)3.77
  • P/E (TTM)19.56
  • Fwd P/E (NTM)0.00
  • EBITDA (TTM)947.907M
  • ROE (TTM)21.39%
  • Revenue (TTM)3.257B
  • Gross Margin (TTM)58.28%
  • Net Margin (TTM)19.24%
  • Debt To Equity (MRQ)7.41%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date07/28/2023
  • Div Amount0.4826
  • Split Date-
  • Split Factor-

Latest On Dr Reddy's Laboratories Ltd

 

Profile

MORE
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global...
Kallam Reddy
Chairman of the Board
Erez Israeli
Chief Executive Officer
Parag Agarwal
Chief Financial Officer
Phanimitra B.
Chief Information Officer
Address
8-2-337, Road No.3 Banjara Hills
Hyderabad
500034
India

Top Peers

SYMBOLLASTCHG%CHG
CAH
Cardinal Health Inc
111.89-0.15-0.13%
BAYRY
Bayer AG
7.67UNCHUNCH
NVO
Novo Nordisk A/S
129.47+1.42+1.11%
VTRS
Viatris Inc
11.85+0.02+0.13%
TEVA
Teva Pharmaceutical Industries Ltd
14.26-0.17-1.21%